Skip to content

BronhoMax Protect

by Hamapharm d.o.o. Croatia EUDAMED

Ref GU0065

EMDN V9017

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-03859892779726 Basic UDI-DIDate16 Feb 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
BronhoMax PROTECT pastile
Model / Reference
GU0065
Primary DI / UDI-DI
03859892779726
Basic UDI-DI
B-03859892779726
EMDN Code
V9017 Oral administration preparations not included in other classes
Device Class
Class I
Market of Registration
Croatia

Manufacturer details

EUDAMED SRN
HR-MF-000023827

Other devices from Hamapharm d.o.o.

See all devices from Hamapharm d.o.o. →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 389afc2f-158d-469e-825d-0bd1621ad5be 61 fields · synced 22 Oct 2026